{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:20:42Z","timestamp":1784751642019,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.burns.2026.108033","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:28:37Z","timestamp":1777523317000},"page":"108033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protective efficacy of a PcrV-based vaccine formulated with chitosan nanoparticles against Pseudomonas aeruginosa infection in burn and sepsis mouse models"],"prefix":"10.1016","volume":"52","author":[{"given":"Hanieh","family":"Jafarvand Atashgah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6605-5245","authenticated-orcid":false,"given":"Setareh","family":"Haghighat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Abdolghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.burns.2026.108033_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00247-23","article-title":"Efficacy of a Pseudomonas aeruginosa serogroup O9 vaccine","volume":"91","author":"Moustafa","year":"2023","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.burns.2026.108033_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae401","article-title":"A computational approach to developing a multi-epitope vaccine for combating Pseudomonas aeruginosa\u2013induced pneumonia and sepsis","volume":"25","author":"Roy","year":"2024","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.burns.2026.108033_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.736882","article-title":"Pseudomonas aeruginosa PcrV enhances the nitric oxide-mediated tumoricidal activity of tumor-associated macrophages via a TLR4\/PI3K\/AKT\/mTOR-glycolysis-nitric oxide circuit","volume":"11","author":"Yu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.burns.2026.108033_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.601601","article-title":"Development of a chimeric vaccine against Pseudomonas aeruginosa based on the Th17-stimulating epitopes of PcrV and AmpC","volume":"11","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.burns.2026.108033_bib5","first-page":"15","article-title":"Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa","volume":"15","author":"Golpasha","year":"2015","journal-title":"Bosn J Basic Med Sci"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s44259-025-00141-z","article-title":"Identification and antimicrobial resistance profiling of Pseudomonas aeruginosa using multi-excitation Raman spectroscopy and computational analytics","volume":"3","author":"Highmore","year":"2025","journal-title":"npj Antimicrob Resist"},{"key":"10.1016\/j.burns.2026.108033_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.tim.2025.05.004","article-title":"Pseudomonas aeruginosa: persistence beyond antibiotic resistance","author":"La Rosa","year":"2025","journal-title":"Trends Microbiol"},{"issue":"12","key":"10.1016\/j.burns.2026.108033_bib8","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.3382\/ps\/pey307","article-title":"Immune efficacy of DNA vaccines based on oprL and oprF genes of Pseudomonas aeruginosa in chickens","volume":"97","author":"Gong","year":"2018","journal-title":"Poult Sci"},{"key":"10.1016\/j.burns.2026.108033_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2147\/DDDT.S189847","article-title":"Mechanistic research holds promise for bacterial vaccines and phage therapies for Pseudomonas aeruginosa","author":"Hoggarth","year":"2019","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13567-020-00762-4","article-title":"Intranasally administered protein coated chitosan nanoparticles encapsulating influenza H9N2 HA2 and M2e mRNA molecules elicit protective immunity against avian influenza viruses in chickens","volume":"51","author":"Hajam","year":"2020","journal-title":"Vet Res"},{"issue":"2","key":"10.1016\/j.burns.2026.108033_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1348-0421.12467","article-title":"Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia","volume":"61","author":"Hamaoka","year":"2017","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.burns.2026.108033_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3389\/fimmu.2019.00781","article-title":"Rational design of a chimeric derivative of PcrV as a subunit vaccine against Pseudomonas aeruginosa","volume":"10","author":"Wan","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.burns.2026.108033_bib13","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3389\/fmicb.2020.01971","article-title":"Type III secretion protein, PcrV, impairs Pseudomonas aeruginosa biofilm formation by increasing M1 macrophage-mediated anti-bacterial activities","volume":"11","author":"Yu","year":"2020","journal-title":"Front Microbiol"},{"issue":"11","key":"10.1016\/j.burns.2026.108033_bib14","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/IAI.00744-10","article-title":"In vivo discrimination of type 3 secretion system-positive and-negative Pseudomonas aeruginosa via a caspase-1-dependent pathway","volume":"78","author":"Wangdi","year":"2010","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.burns.2026.108033_bib15","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1016\/j.ymthe.2025.09.025","article-title":"Harnessing mRNA-encoded PcrV-targeting monoclonal antibodies for combating antibiotic-resistant P. aeruginosa infections","volume":"33","author":"Wang","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.burns.2026.108033_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1043109","article-title":"New-age vaccine adjuvants, their development, and future perspective","volume":"14","author":"Verma","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-018-0089-x","article-title":"Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want","volume":"3","author":"HogenEsch","year":"2018","journal-title":"npj Vaccin"},{"issue":"4","key":"10.1016\/j.burns.2026.108033_bib18","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3390\/pharmaceutics15041238","article-title":"Pulmonary application of novel antigen-loaded chitosan nano-particles co-administered with the mucosal adjuvant C-Di-AMP resulted in enhanced immune stimulation and dose sparing capacity","volume":"15","author":"Ebensen","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41598-022-05157-3","article-title":"Vaccination of mice with hybrid protein containing Exotoxin S and PcrV with adjuvants alum and MPL protects Pseudomonas aeruginosa infections","volume":"12","author":"Asadi Karam","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.burns.2026.108033_bib20","first-page":"731","article-title":"Aluminium-adjuvanted vaccines\u2013a review of the current state of knowledge","volume":"69","author":"Go\u0142o\u015b","year":"2015","journal-title":"Przegl Epidemiol"},{"key":"10.1016\/j.burns.2026.108033_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106033","article-title":"A chimeric vaccine targeting Pseudomonas aeruginosa virulence factors protects mice against lethal infection","volume":"178","author":"Korpi","year":"2023","journal-title":"Microb Pathog"},{"issue":"12","key":"10.1016\/j.burns.2026.108033_bib22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.17221\/86\/2021-VETMED","article-title":"Immune responses and protective efficacy of a trivalent combination DNA vaccine based on oprL, oprF and flgE genes of Pseudomonas aeruginosa","volume":"67","author":"Gong","year":"2022","journal-title":"Vet Med"},{"issue":"6","key":"10.1016\/j.burns.2026.108033_bib23","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/vaccines11061088","article-title":"Effect of a novel trivalent vaccine formulation against acute lung injury caused by Pseudomonas aeruginosa","volume":"11","author":"Inoue","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.burns.2026.108033_bib24","article-title":"Self-assembled ferritin nanoparticles displaying PcrV and OprI as an adjuvant-free Pseudomonas aeruginosa vaccine","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-00449-w","article-title":"Augmenting phage therapy using green nanotechnology for promising infection control, wound healing and devoiding phage resistance in MDR Pseudomonas aeruginosa","volume":"15","author":"Mani","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib26","doi-asserted-by":"crossref","first-page":"9088","DOI":"10.1038\/s41598-024-59866-y","article-title":"An effective antibiofilm strategy based on bacteriophages armed with silver nanoparticles","volume":"14","author":"Szymczak","year":"2024","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.burns.2026.108033_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2024.103569","article-title":"Chitosan-nanoparticle-based oral Salmonella enteritidis subunit vaccine elicits cross-protection against Salmonella typhimurium in broilers","volume":"103","author":"Dolatyabi","year":"2024","journal-title":"Poult Sci"},{"key":"10.1016\/j.burns.2026.108033_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.aca.2014.10.009","article-title":"Bioanalytical chemistry of cytokines\u2013a review","volume":"853","author":"Stenken","year":"2015","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.burns.2026.108033_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103945","article-title":"Recombinant PBP2a of methicillin-resistant S. aureus formulation in Alum and Montanide ISA266 adjuvants induced cellular and humoral immune responses with protection in Balb\/C mice","volume":"140","author":"Mortazavi","year":"2020","journal-title":"Microb Pathog"},{"issue":"5","key":"10.1016\/j.burns.2026.108033_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.burns.2010.12.003","article-title":"Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis","volume":"37","author":"Faezi","year":"2011","journal-title":"Burns"},{"issue":"6","key":"10.1016\/j.burns.2026.108033_bib31","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/infdis\/131.6.688","article-title":"Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model","volume":"131","author":"Stieritz","year":"1975","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.burns.2026.108033_bib32","first-page":"121","article-title":"In-silico analysis and protective efficacy of the PcrV recombinant vaccine against Pseudomonas aeruginosa in the burned and PA-infected BALB\/c mouse model","volume":"17","author":"Fakoor","year":"2020","journal-title":"Iran J Immunol"},{"issue":"2","key":"10.1016\/j.burns.2026.108033_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/apm.12101","article-title":"Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection","volume":"122","author":"Faezi","year":"2014","journal-title":"Apmis"},{"key":"10.1016\/j.burns.2026.108033_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1508941","article-title":"Multidrug resistance of Pseudomonas aeruginosa: do virulence properties impact on resistance patterns?","volume":"16","author":"Saha","year":"2025","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/cells12010199","article-title":"Pseudomonas aeruginosa: infections, animal modeling, and therapeutics","volume":"12","author":"Wood","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.burns.2026.108033_bib36","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3390\/ijms26052012","article-title":"Pseudomonas aeruginosa vaccine development: lessons, challenges, and future innovations","volume":"26","author":"Santamarina-Fern\u00e1ndez","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.burns.2026.108033_bib37","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2147\/IDR.S244081","article-title":"Protective efficacy of the OprF\/OprI\/PcrV recombinant chimeric protein against Pseudomonas aeruginosa in the burned BALB\/c mouse model","author":"Fakoor","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib38","article-title":"Designing a multi-epitope vaccine against Pseudomonas aeruginosa via integrating reverse vaccinology with immunoinformatics approaches","volume":"15","author":"Zhu","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.burns.2026.108033_bib39","series-title":"Seminars in immunology","article-title":"Nanoparticles and innate immunity: new perspectives on host defence","year":"2017"},{"issue":"7","key":"10.1016\/j.burns.2026.108033_bib40","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/17425247.2019.1641083","article-title":"Recent advances in aerosol gene delivery systems using non-viral vectors for lung cancer therapy","volume":"16","author":"Lee","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"10.1016\/j.burns.2026.108033_bib41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s13205-020-2076-y","article-title":"Chitosan and chitosan nanoparticles as adjuvant in local Rift Valley Fever inactivated vaccine","volume":"10","author":"El-Sissi","year":"2020","journal-title":"3 Biotech"},{"issue":"3","key":"10.1016\/j.burns.2026.108033_bib42","first-page":"385","article-title":"Effectiveness of chitosan nanoparticles in development of pentavalent clostridial toxoid vaccine in terms of clinical pathology elements and immunological responses","volume":"75","author":"Hemmaty","year":"2020","journal-title":"Arch Razi Inst"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12885-023-10614-x","article-title":"Preparation of chitosan nanoparticle containing recombinant CD44v antigen and evaluation of its immunization capacity against breast cancer in BALB\/c mice","volume":"23","author":"Gheybi","year":"2023","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.burns.2026.108033_bib44","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3390\/pharmaceutics14081671","article-title":"Protein-based adjuvants for vaccines as immunomodulators of the innate and adaptive immune response: current knowledge, challenges, and future opportunities","volume":"14","author":"D\u00edaz-Dinamarca","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.burns.2026.108033_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104953","article-title":"Molecular cloning and immunogenicity evaluation of IsdE protein of methicillin resistant Staphylococcus aureus as vaccine candidates","volume":"157","author":"Vahdani","year":"2021","journal-title":"Microb Pathog"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11274-022-03455-6","article-title":"Synthetic selenium nanoparticles as co-adjuvant improved immune responses against methicillin-resistant Staphylococcus aureus","volume":"39","author":"Ranjbariyan","year":"2023","journal-title":"World J Microbiol Biotechnol"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib47","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1080\/10717544.2017.1388450","article-title":"Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration","volume":"24","author":"Zhao","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.burns.2026.108033_bib48","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.2147\/IJN.S301851","article-title":"Nanoparticles of chitosan\/Poly (D, L-Lactide-Co-Glycolide) enhanced the immune responses of haemonchus contortus HCA59 antigen in model mice","author":"Wang","year":"2021","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.burns.2026.108033_bib49","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3389\/fimmu.2018.00562","article-title":"Trimethyl chitosan nanoparticles encapsulated protective antigen protects the mice against anthrax","volume":"9","author":"Malik","year":"2018","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.burns.2026.108033_bib50","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1080\/21645515.2021.1884473","article-title":"Whole inactivated dengue virus-loaded trimethyl chitosan nanoparticle-based vaccine: immunogenic properties in ex vivo and in vivo models","volume":"17","author":"Jearanaiwitayakul","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12951-018-0337-2","article-title":"Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection","volume":"16","author":"Huang","year":"2018","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"10.1016\/j.burns.2026.108033_bib52","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/vms3.537","article-title":"Evaluation of the immunogenicity and efficacy of a chimeric OMP25\u2013OMP31 antigen in BALB\/c mice","volume":"7","author":"Mohammadi","year":"2021","journal-title":"Vet Med Sci"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12917-023-03632-1","article-title":"Nigella sativa-chitosan nanoparticles: novel intestinal mucosal immunomodulator controls and protects against Salmonella enterica serovar Enteritidis infection in broilers","volume":"19","author":"Ahmad","year":"2023","journal-title":"BMC Vet Res"},{"issue":"3","key":"10.1016\/j.burns.2026.108033_bib54","first-page":"435","article-title":"New modular platform based on multi-adjuvanted amphiphilic chitosan nanoparticles for efficient lipopeptide vaccine delivery against group A streptococcus","volume":"17","author":"Norpi","year":"2022","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.burns.2026.108033_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116264","article-title":"Enhanced protective efficacy of an OprF\/PcrV bivalent DNA vaccine against Pseudomonas aeruginosa using a hydrogel delivery system","volume":"172","author":"Zhang","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-26846-z","article-title":"Pseudomonas aeruginosa PAO1 outer membrane vesicles-diphtheria toxoid conjugate as a vaccine candidate in a murine burn model","volume":"12","author":"Zare Banadkoki","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.burns.2026.108033_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096609","article-title":"Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa infection","volume":"9","author":"Jiang","year":"2014","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.burns.2026.108033_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijpharm.2018.09.044","article-title":"Mechanistic study of the adjuvant effect of chitosan-aluminum nanoparticles","volume":"552","author":"Lebre","year":"2018","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.burns.2026.108033_bib59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/vaccines4040040","article-title":"Edwardsiella tarda OmpA encapsulated in chitosan nanoparticles shows superior protection over inactivated whole cell vaccine in orally vaccinated fringed-lipped peninsula carp (Labeo fimbriatus)","volume":"4","author":"Dubey","year":"2016","journal-title":"Vaccines"},{"key":"10.1016\/j.burns.2026.108033_bib60","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3389\/fcimb.2017.00445","article-title":"Intranasal vaccination with mannosylated chitosan formulated DNA vaccine enables robust IgA and cellular response induction in the lungs of mice and improves protection against pulmonary mycobacterial challenge","volume":"7","author":"Wu","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.burns.2026.108033_bib61","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3389\/fimmu.2018.00934","article-title":"Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs","volume":"9","author":"Dhakal","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.burns.2026.108033_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2019.151362","article-title":"Elicitation of Th1\/Th2 related responses in mice by chitosan nanoparticles loaded with Brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19","volume":"310","author":"Shim","year":"2020","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.burns.2026.108033_bib63","first-page":"159","article-title":"Immunogenicity evaluation of recombinant Staphylococcus aureus enterotoxin B (rSEB) and rSEB-loaded chitosan nanoparticles following nasal administration","author":"Hosseini","year":"2020","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"10","key":"10.1016\/j.burns.2026.108033_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00091-21","article-title":"A nonlethal murine flame burn model leads to a transient reduction in host defenses and enhanced susceptibility to lethal Pseudomonas aeruginosa infection","volume":"89","author":"Brammer","year":"2021","journal-title":"Infect Immun"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417926001853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417926001853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:43:19Z","timestamp":1784749399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417926001853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0305417926001853"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2026.108033","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective efficacy of a PcrV-based vaccine formulated with chitosan nanoparticles against Pseudomonas aeruginosa infection in burn and sepsis mouse models","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2026.108033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and ISBI. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108033"}}